RACHAEL A. REAM
Rachael A. Ream, J.D., Ph.D. has represented hospitals, physician groups, pharmacies, and other health care clients in strategic transactions, such as mergers and acquisitions, private equity transactions, joint ventures and physician contracting matters, including co-management arrangements, physician recruitment agreements, and employment and medical director agreements. Ms. Ream regularly assists clients with Medicaid audits, pharmacy audits, and responding to Statements of Deficiency. She also drafts and negotiates strategic supply management and equipment leasing and purchase agreements.
Ms. Ream represents clients on compliance matters, including defense of Medicare and Medicaid fraud and abuse cases, EMTALA, audits. She also advises clients regarding Anti-Kickback Statute and Stark Law compliance and HIPAA and HITECH compliance. She has experience conducting compliance risk assessments and GAP analyses, drafting compliance policies and procedures, and conducting compliance training.
Ms. Ream has extensive background in academic research and has represented clients in the area of research law, including negotiating Material Transfer Agreements, IRB Agreements, Clinical Trial Agreements, and the Common Rule. She earned a Ph.D. in Biological Sciences from Stanford University and completed a post-doctoral research fellowship in Biochemistry at Stanford University School of Medicine. Prior to graduating from Case Western Reserve University School of Law, Ms. Ream worked as a medical writer and editor in clinical research and helped clients prepare for FDA advisory panels.
Bachelor of Science, University of Toledo, cum laude, 1996
Doctor of Philosophy, Stanford University, 2002
Juris Doctor, Case Western Reserve University School of Law, magna cum laude, 2008
Bar of Ohio
Bar of Oregon
Bar of Washington
American Health Lawyers Association
American Society of Pharmacy Law
Washington State Bar Association
Washington State Society of Healthcare Attorneys
Order of the Coif
Case Western Reserve University Law Review – Publisher
“ASC Models: A Comparison of Management Service Organization and Private Equity Investments,” Pacific Northwest ASC Symposium, May 24, 2019
“Demystifying Buprenorphine Opiate Addiction Treatment,” American Society of Pharmacy Law Fall Meeting, November 2, 2018
“Revisiting Charity Care and Beneficiary Inducements in the Light of New Guidance,” Oregon Rural Health Conference, October 5, 2018
“The Puzzle of Pharmacists as Providers: Fitting the Pieces Together to Cover Rural Communities,” Oregon Rural Health Conference, October 4, 2018
“ASCs: The Role of Private Equity,” Pacific Northwest ASC Symposium, July 26, 2018
503.468.5995, Ext. 103